Through the attached link we are happy to inform you about a major strategic agreement between Incyte and Agenus, both listed on the NASDAQ stock exchange. The Agenus programs now partnered had their origins in 4-Antibody, a LSP portfolio company which we have combined with Agenus in 2014. This alliance validates our intention at the time to help create a leading player in the exciting field of immuno-oncology.
« back to overview
Follow us
Through the attached link we are happy to inform you about a major strategic agreement between Incyte and Agenus, both listed on the NASDAQ stock exchange. The Agenus programs now partnered had their origins in 4-Antibody, a LSP portfolio company which we have combined with Agenus in 2014. This alliance validates our intention at the time to help create a leading player in the exciting field of immuno-oncology.
« back to overview
